新世界(00017.HK)旗下Humansa與貝康國際SAINT BELLA簽定戰略合作協議
新世界(00017.HK)旗下醫療健康業務Humansa宣布,日前與貝康國際旗下的SAINT BELLA簽定戰略合作協議。
貝康國際旗下SAINT BELLA是業內發展最迅速的高端母嬰護理中心品牌,與全球頂級酒店品牌合作,提供全方位坐月住宿服務。首階段合作將計劃在香港和內地共同打造4間高端月子會所,首個服務點將入駐香港Victoria Dockside的K11 ARTUS,成為Humansa個人化一站式專業醫療及身心健康服務的重點項目之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.